The Diagnostic Specialty Enzymes Market was valued at US$ 1.0 billion in 2022 and is projected to grow at a CAGR of 6.9% from ...

Roche Diagnostics is collaborating with the University of Liverpool to launch the Eye Cancer Artificial Intelligence Digital ...

The programme aims to enhance early detection and ensure timely, accurate breast cancer diagnosis by offering free immunohistochemistry tests, multidisciplinary care, and navigation services to 5,000 ...

This week the University of Liverpool launched the Eye Cancer Artificial Intelligence Digital Bioresource (EYE-CAN-AID), an ...

Rise in prevalence of cancer and the necessary attention in early diagnosis and treatment to boost market demand, States Fact.MRRockville, MD, ...

The global HIV diagnostics market, valued at US$2.96B in 2024, is forecasted to grow at a 10.3% CAGR, reaching US$3.25B by ...

The POC Diagnostics Market is expected to grow from an estimated USD 51.26 billion in 2024 to USD 118.91 billion in 2033, at a CAGR of 9.8%. The global point-of-care (POC) diagnostics market is ...

Such tests are increasingly moving beyond their origins in cutting-edge research and into the laboratory and diagnostic ...

The global clinical chemistry analyzers market is on a robust growth trajectory, projected to reach USD 14,932.2 million in 2024. With a steady compound annual growth rate (CAGR) of 4.8% between 2024 ...

Siemens Healthineers has established a formidable presence in imaging and radiotherapy through the acquisition of Varian. Now, it is refocusing its diagnostic operations, the weakest piece among ...

Roche's rejuvenated drug portfolio and increased free cash flow signal a potential turnaround, but long-term charts and past performance warrant caution. Diagnostics business and AI integration ...